Cassava Paying $40 Million to Settle Doctored Alzheimer's Drug Data Claims
The Securities and Exchange Commission alleged {that a} researcher for the corporate manipulated trial knowledge to make its drug outcomes look extra promising. More
Don't have an account? Register
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. GDPR Privacy policy
AcceptHere you'll find all collections you've created before.